Existing users please login

Forgot Password

    Home / Markets / Industries / Health Care

    Friday, November 06, 2009

    Boston Scientific Settles with Justice Department

    | Respond to Editor | Print

     
    FOXBusiness
       

      Boston Scientific (BSX), the medical device maker, said it will pay $296 million to settle an investigation by the Department of Justice into the company’s Guidant division.

      The settlement involved claims that Guidant knowingly sold defective defibrillators for three years that had potentially life-threatening imperfections. Although the company notified patients and doctors about the problem, it was criticized for dragging its feet during this process.

      Boston Scientific has updated its third-quarter results to include the payment. Its third-quarter loss now stands at $94 million, or 6 cents per share, instead of the $250 million profit, or 13 cents per-share, it previously reported. 

      Shares of Boston Scientific are flat at $8.07. 

      Fox Business Video


      Last 5 Stocks

      • Ticker
      • Company
      • Price
      • Change
       

      Personal Finance - Investing - Financial News - Business News - Stock Market Quotes & News - Small Business

      Advertise with us | Jobs at FOX Business Network | Internships at FBN

      Terms of use. Privacy Statement. For FOXBusiness.com technical issues write to foxbusinessonline@foxbusiness.com; for all other feedback, write to feedback@foxbusiness.com.

      Quotes delayed at least 15 minutes. Market Data provided by Interactive Data (Terms & Conditions). Powered and implemented by Interactive Data Managed Solutions. Company fundamental data provided by Morningstar. Earnings estimates data provided by Zacks. Mutual fund data provided by Lipper. Economic data provided by Econoday. Dow Jones & Company Terms & Conditions.

      This material may not be published, broadcast, rewritten, or redistributed. ©2010 FOX News Network, LLC. All rights reserved.